Inventors: Dr. Meenal Kowshik, Dr. Indrani Talukdar

The development of biocompatible nanotechnology-based non-viral delivery vehicles for micro-dystrophin gene delivery aims to treat Duchenne muscular dystrophy (DMD). These vehicles utilize nanoparticles engineered with biocompatible materials to safely transport micro-dystrophin genes into muscle cells. By evading immune responses and enhancing cellular uptake, they facilitate gene expression, promoting muscle fiber.